Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 16, Pages -Publisher
MDPI
DOI: 10.3390/ijms23169344
Keywords
inflammatory bowel disease; ulcerative colitis; Crohn's disease; murine models; therapeutics
Funding
- EUROPEAN COMMISSION [65739]
- NATIONAL RESEARCH FOUNDATION [99074]
Ask authors/readers for more resources
This article reviews the current murine models used for studying human inflammatory bowel disease, including chemical-induced models, gene-deficient models, and cell transfer models. The application and limitations of these models in understanding the disease pathogenesis and developing new clinical treatment strategies are discussed.
Crohn's disease (CD) and ulcerative colitis (UC) are both highly inflammatory diseases of the gastrointestinal tract, collectively known as inflammatory bowel disease (IBD). Although the cause of IBD is still unclear, several experimental IBD murine models have enabled researchers to make great inroads into understanding human IBD pathology. Here, we discuss the current pre-clinical experimental murine models for human IBD, including the chemical-induced trinitrobenzene sulfonic acid (TNBS) model, oxazolone and dextran sulphate sodium (DSS) models, the gene-deficient I-kappa-B kinase gamma (I kappa kappa-gamma) and interleukin(IL)-10 models, and the CD4(+) T-cell transfer model. We offer a comprehensive review of how these models have been used to dissect the etiopathogenesis of disease, alongside their limitations. Furthermore, the way in which this knowledge has led to the translation of experimental findings into novel clinical therapeutics is also discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available